CEO of Botox maker vows to limit price hikes

Posted online September 8, 2016 | 11:42 am

Brent Saunders, CEO of drugmaker Allergan, in a blog post criticized a recent spate of controversial drug price hikes.

He didn't mention any drugmaker's pricing decisions by name, but he said, "I understand the public outcry and add my voice to the condemnation of these behaviors."

Saunders pledged Allergan's price increases - such as for its drug Botox - would be less than 10 percent and limited to once a year.

Read more from CNNMoney.

Comments

No comments on this story |

Please log in to add your comment

Prater's nomination for State Board of Education pulled by Kehoe

Editors' Pick

Open for Business: Dame Chiropractic

Dame Chiropractic LLC emerged as the new name of Harshman Chiropractic Clinic LLC with the purchase of the business; Leo Kim added a second venture, Keikeu LLC, to 14 Mill Market; and Mercy Springfield Communities opened its second primary care clinic in Ozark.

Most Read